Neurodermatitis
RecruitingICP-332 for Adults with Prurigo Nodularis
ICP-332 for Adults with Prurigo Nodularis
- Disease:Neurodermatitis
- Substances:–
Germany- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Back to Germany978 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)ICP-332 for Adults with Prurigo Nodularis
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
GermanyGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GermanyA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
GermanyComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyVolrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
GermanyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
GermanyHigh-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency
GermanyA study to compare the effectiveness of bupivacaine hydrochloride monohydrate and lidocaine hydrochloride for treating mouth sores in patients with head and neck cancer.
GermanyA study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy
GermanyA study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.